Effects of Cannabidiol on Stress and Nicotine Withdrawal
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT07001930
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- CBD
- Nicotine Dependence
- Stress
- Tobacco Smoking
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Epidiolex — DRUGOral cannabidiol
Study Details
The purpose of this study is to examine the effect of doses of cannabidiol (CBD) during exposure to stress and nicotine withdrawal in nicotine users. The main objectives of the study include examining the effect CBD has on stress, tobacco dependence, tobacco withdrawal, and sex differences between these types of stress. Participants will be administered CBD and exposed to stress. Biological and subjective measures will be collected. Participants may be asked to stop use for 24 hours. Researchers will also investigate withdrawal effects between participants who have not smoked nicotine in 24 hours and those who have continued to smoke before each session.
Key Dates
- Start date
- Aug 25, 2025
- Status verified
- Aug 2025
- Primary completion
- Sep 1, 2029
- Completion
- Sep 1, 2029
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- OTHER
Arms
- Experimental: Ad Lib (first)Participants who use tobacco cigarettes and will be randomly assigned to smoking ab lib. Each participant will receive 0, 200, 400 mg of CBD in this arm.
- Experimental: Abstinence (first)Participants who use tobacco cigarettes and will be randomly assigned to smoking abstinence for 24 hours before each session. Each participant will receive 0, 200, 400 mg of CBD in this arm.
Primary Outcome Measure
Negative Affect as assessed by the Subjective State Scale [ Time Frame: 20 minutes, 70 minutes, 120 minutes, 170 minutes, 190 minutes, 200 minutes, 220 minutes timepoints ]
Central Contacts
- Lauren Brogdon, MHS410-550-6953
- Dustin C. Lee, PhD410-550-4035
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Behavioral Pharmacology Research Unit | Baltimore | Maryland | 21224 | - |
Find similar trials in Baltimore, MD
Related Studies
- Advanced Functional and Structural MRI Techniques for Neuropharmacological ImagingRecruiting · National Institute on Drug Abuse (NIDA) · Baltimore, Maryland
- Oral Cannabidiol for Tobacco CessationPHASE1 · Recruiting · Johns Hopkins University · Baltimore, Maryland
- Orexin s Role in the Neurobiology of Substance Use DisorderRecruiting · National Institute on Drug Abuse (NIDA) · Baltimore, Maryland
- State-dependent Interoception, Value-based Decision-making, and IntrospectionRecruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland